Frank, You make some great points. If a company believes they have a bright future, it only goes to follow that they would be vocal about it. Silence stinks of deceit. Stock price is a reflection of many aspects of a company... chief among them it's foundation, it's current assets, it's future possibilities. For ACMI, clearly the foundations are set; it's FDA-approved product line speaks for itself. It's current situation is rocky, higher than expected LOSSES, decreasing margins (although they are extremely high in the first place), competitors lurking. This is what impedes a prospective investor from diving in. However, with revenues increasing at phenomenal proportions year over year, EARNINGS are on the horizon. The products Accumed offer could really become industry standards. This will take money, for marketing, production expansion, etc... To increase the value of shares will not only create a stable investor core, but increase the value of a stock offering.
It all starts with productive PR and IR departments.
Sorry for the rambling message, RYAN
P.S. ACMI has approximately 22 million shares on the market, right?
I wonder how many shares are represented by this thread? |
